Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 1-6.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Sah P, Vilches TN, Moghadas SM, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP, Return on investment of the COVID-19 vaccination campaign in New York City, JAMA Network Open 2022, 5(11): e2243127.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Li A, Wu J, Moghadas SM, Epidemic dynamics with time-varying transmission risk reveal the role of disease stage-dependent infectiousness, Journal of Theoretical Biology 2023, 573: 111594.
Fitzpatrick MC, Moghadas SM, Vilches TN, Shah A, Pandey A, Galvani AP, Estimated US pediatric hospitalizations and school absenteeism associated with accelerated COVID-19 bivalent booster vaccination, JAMA Network Open 2023, 6(5): e2313586.
Pandey A, Wells CR, Stadnytskyi V, Sah P, Moghadas SM, Marathe M, Singer BH, Nesterova O, Galvani AP, Disease burden among Ukrainians forcibly displaced by the 2022 Russian invasion, Proceedings of the National Academy of Sciences USA 2023, 120(8): e2215424120.
Shi C, Vilches TN, Li A, Wu J, Moghadas SM, Modelling mutation-driven emergence of drug-resistance: a case study of SARS-CoV-2, Book Chapter, Springer 2023, 161–174.
Li A, Wang Z, Moghadas SM, Modelling the impact of timelines of testing and isolation on disease control, Infectious Disease Modelling 2023, 8: 58–71.
Sah P, Vilches TN, Moghadas SM, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP, Return on investment of the COVID-19 vaccination campaign in New York City, JAMA Network Open 2022, 5(11): e2243127.
Vilches TN, Rafferty E, Wells CR, GalvaniAP, Moghadas SM, Economic evaluation of COVID-19 rapid antigen screening programs in the workplace, BMC Medicine 2022, 20: 452.
Wells CR, Pandey A, Gokcebel S, Krieger G, Donoghue M, Singer BH, Moghadas SM, Galvani AP, Townsend JP, Quarantine and serial testing for variants of SARS-CoV-2 with benefits of vaccination and boosting on consequent control of COVID-19, PNAS - NEXUS 2022, 1(3): 1–6.
Sah P, Vilches TN, Pandey A, Schneider EC,Moghadas SM, Galvani AP, Estimating the impact of vaccination on reducing COVID-19 burden in the United States: December 2020 to March 2022, Journal of Global Health 2022, 12: 03062.
Abdollahi E, Keynan Y,Foucault P, Brophy J, Sheffield H, Moghadas SM, Evaluation of TB elimination strategies in Canadian Inuit populations: Nunavut as a case study, Infectious Disease Modelling 2022, 7(4): 698-708.